Why is SNDX Down Today?
About Syndax Pharmaceuticals, Inc.
Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. Its product candidates include revumenib and axatilimab. It is developing revumenib, a selective menin-MLL inhibitor for KMT2A-rearranged...
Overall Confidence: 65%
Based on news, social sentiment, options activity, and sector analysis
✅ Move Confirmation
UNCONFIRMED - Low volume suggests this move may not be sustainable.
📍 Sector Context
PHARMACEUTICAL PREPARATIONS sector: -2.2%
Market Comparison
🔔 Get SNDX Alerts
We'll notify you when SNDX's trend changes or a new signal fires.
Data refreshes every 30 minutes during market hours
Historical Context
SNDX has moved more than 3.0% down on 42 occasions in the past year.
Frequently Asked Questions
Why is SNDX stock down today?
This appears to be a sector-wide move. The PHARMACEUTICAL PREPARATIONS sector is down 2.2% on average.
Is SNDX stock a buy or sell right now?
Based on current analysis, SNDX shows 65% confidence in today's move. Volume is low which does not confirm the trend. View full buy/sell analysis →
What is the SNDX stock price target?
SNDX is currently trading at $9.34. Based on today's momentum, the expected short-term range is $9.06 - $9.53. See long-term price prediction →
Will SNDX stock continue falling?
Our analysis shows a 45% probability that SNDX's move continues in the next 1-3 days. Key level to watch: $8.87 (support).
Is SNDX stock oversold or overbought?
SNDX's RSI (Relative Strength Index) is currently at 25.9. This indicates oversold conditions - the stock may be due for a bounce as selling pressure appears exhausted.
What is the momentum for SNDX stock?
SNDX's 10-day momentum indicator is at -4.2. Strong bearish momentum - the stock is experiencing significant downward pressure. Watch for potential reversal signals.
Is SNDX outperforming or underperforming the market?
SNDX (-2.20%) is currently underperforming the market (-1.8% vs SPY). Today, the S&P 500 (SPY) is down -0.37%, and Nasdaq (QQQ) is down -0.68%.
What does MACD indicate for SNDX?
SNDX's MACD (-1.72) is currently below the signal line (-1.42), indicating a bearish trend. This technical signal suggests selling pressure is dominant. The trend strength (ADX: 46.2) is strong.
Is SNDX in an uptrend or downtrend?
Based on moving average analysis, SNDX is in a bearish trend. The price ($9.34) is trading below both the 20-day SMA ($12.57) and 50-day SMA ($15.93). This alignment typically indicates sustained downward pressure.
Check Why Another Stock is Moving
Enter any ticker symbol to see real-time analysis